𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of somatostatin receptor types 1–5 in 81 cases of gastrointestinal and pancreatic endocrine tumors

✍ Scribed by M. Papotti; M. Bongiovanni; M. Volante; E. Allìa; S. Landolfi; L. Helboe; M. Schindler; S. Cole; G. Bussolati


Publisher
Springer
Year
2002
Tongue
English
Weight
625 KB
Volume
440
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Somatostatin receptor subtypes sst1, sst
✍ Jean-Claude Schaer; Beatrice Waser; Guadalupe Mengod; Jean Claude Reubi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 692 KB

Using in situ hybridization techniques with selective oligoprobes, the gene expression of sst 1 , sst 2 , sst 3 and sst 5 was studied in a series of 32 human pituitary adenomas, 28 breast tumors and 21 endocrine gastroentero-pancreatic tumors, shown to express somatostatin receptors to variable exte

Progesterone receptor immunoreactivity i
✍ Giuseppe Viale; Claudio Doglioni; Marcello Gambacorta; Giuseppe Zamboni; Guido C 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 961 KB

Background. The immunoreactivity for progesterone receptors (PR) of the majority of endocrine cells of the human pancreas has prompted the authors to investigate if PR expression is maintained in pancreatic endocrine tumors and is correlated with the main clinicopathologic features of these neoplasm

Anti-Cytokeratin CAM5.2 Reagent (Becton
✍ Pin-Jie Chen; Jeng-Dong Hsu; Chih-Ping Han 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB

W e read with great interest the article enti- tled ''Sonographic Findings in a Patient with Neurofibromatosis Type 1 and a Gastrointestinal Stromal Tumor'' by Girtler and colleagues. 1 However, one aspect of this article requires clarification, as the authors may have inadvertently interpreted CAM5